Biolegend, 109821, Alexa Fluor® 700 anti-mouse CD45.2 Antibody, 25μg

CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
25μg
Verified Reactivity: Mouse
Antibody Type: Monoclonal
Host Species: Mouse
Immunogen: B10.S mouse thymocytes and splenocytes
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography and conjugated with Alexa Fluor® 700 under optimal conditions.
Concentration: 0.5 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application: FC - Quality tested
Recommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is highly recommended that the reagent be titrated for optimal performance for each application.* Alexa Fluor® 700 has a maximum emission of 719 nm when it is excited at 633 nm / 635 nm. Prior to using Alexa Fluor® 700 conjugate for flow cytometric analysis, please verify your flow cytometer's capability of exciting and detecting the fluorochrome.Alexa Fluor® and Pacific Blue™ are trademarks of Life Technologies Corporation.View full statement regarding label licenses
Excitation Laser: Red Laser (633 nm)
Application Notes: The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.
Application References(PubMed link indicates BioLegend citation): Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block) Yakura H, et al. 1986. J. Immunol. 136:2729. (Block) Suzuki K, et al. 2000. Immunity 13:691. (IHC) Shen FW, et al. 1986. Immunogenetics 24:146. (IP) Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837. Pascal V, et al. 2007. J. Immunol. 179:1751. Burman AC, et al. 2007. Blood 110:1064. Kincaid EZ, et al. 2007. J. Immunol. 179:3187. Phan TG, et al. 2007. Nature Immunol. 8:992. Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed Wen T, et al. 2013. PNAS. 110:6067. PubMed Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
Product Citations: Basu S, et al. 2013. J Immunol Methods. 396:163. PubMed Bradley CP et al. 2017. Cell host & microbe. 22(5):697-704 . PubMed Wu J et al. 2017. Immunity. 47(6):1114-1128 . PubMed Chandran S, et al. 2020. Front Immunol. 11:787. PubMed Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed Guo A, et al. 2022. Nature. 607:135. PubMed Shiroshita K, et al. 2022. Cell Rep Methods. 2:100354. PubMed Guo D, et al. 2023. Cell Biosci. 13:51. PubMed Haensel D, et al. 2023. Nat Commun. 14:2685. PubMed Vella JL, et al. 2021. Life Sci Alliance. 4:. PubMed Su Y, et al. 2022. J Hematol Oncol. 15:99. PubMed Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed Behr FM, et al. 2021. Eur J Immunol. 51:151. PubMed Herz J, et al. 2021. Neuron. 109:3609. PubMed Kragten NAM, et al. 2022. Eur J Immunol. 52:389. PubMed Mirchandani AS, et al. 2022. Nat Immunol. 23:927. PubMed Du Y, et al. 2022. J Exp Med. 219: . PubMed Horkova V, et al. 2023. Nat Immunol. 24:174. PubMed du Halgouet A, et al. 2023. Immunity. 56:78. PubMed Arimoto KI, et al. 2023. Nat Commun. 14:251. PubMed Novaj A, et al. 2023. Int J Mol Sci. 24: . PubMed Sylvester MA, et al. 2022. Am J Physiol Renal Physiol. 322:F245. PubMed Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed Zinselmeyer B, et al. 2013. J Exp Med. 210:757. PubMed Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed Page N, et al. 2018. Immunity. 48:937. PubMed Ferrere G, et al. 2021. JCI Insight. 6:. PubMed Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed Baptista AP et al. 2019. Immunity. 50(5):1188-1201 . PubMed Ersching J et al. 2017. Immunity. 46(6):1045-1058 . PubMed Zhang J, et al. 2021. MedComm (Beijing). 2:256. PubMed Plumlee CR, et al. 2020. Cell Host Microbe. 29(1):68-82.e5. PubMed Semmrich M, et al. 2011. Mucosal Immunol. 0.3125. PubMed Kang S, et al. 2011. J Exp Med. 208:747. PubMed Böttcher JP, et al. 2018. Cell. 172:1022. PubMed Blackburn CMR, et al. 2021. Atherosclerosis. 330:76. PubMed Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed Liu X, et al. 2021. eLife. 0.416666666666667. PubMed Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed Louveau A, et al. 2018. Nat Neurosci. 21:1380. PubMed Inoue D, et al. 2021. Nat Genet. 53:707. PubMed Yoshimi A, et al. 2019. Nature. 574:273. PubMed Ciecko AE, et al. 2019. Cell Rep. 29:3073. PubMed Kretschmer B, et al. 2015. Immunobiology. 220: 964-975. PubMed Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed Amor C, et al. 2020. Nature. 583:127. PubMed He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed He J, et al. 2020. Cell Reports. 29(9):2718-2730.e6.. PubMed Salei N, et al. 2020. J Am Soc Nephrol. 31:257. PubMed DeFranco D 2014. Proc Natl Acad Sci U S A. 111:3224. PubMed Zenke S, et al. 2020. Immunity. 52(2):313-327. PubMed Di Genua C, et al. 2020. Cancer Cell. 37(5):690-704.e8.. PubMed Fallet B, et al. 2020. Cell Rep. 30:1013. PubMed Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed Adams NM et al. 2018. Immunity. 48(6):1172-1182 . PubMed Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed Kinkel SA, et al. 2022. iScience. 25:104684. PubMed Trompette A, et al. 2022. Mucosal Immunol. :. PubMed Amos J, et al. 2015. J Virol. 89: 9485-9498. PubMed Wiedemann GM, et al. 2020. Cell Rep. 33:108498. PubMed Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed Diaz–Salazar C, et al. 2020. Cell Rep. 32:108186. PubMed Lee SS, et al. 2022. Commun Biol. 5:654. PubMed Markey K, et al. 2014. J Immunol. 192:5426. PubMed Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed Patel S, et al. 2019. Viruses. 0.877083333. PubMed Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed Booth CAG, et al. 2018. Cancer Cell. 33:274. PubMed Luck H, et al. 2015. Cell Metab. 21 527 . PubMed Kruta M, et al. 2021. Cell Stem Cell. :. PubMed Zaid A,et al. 2017. J Immunol. 10.4049/jimmunol.1700571. PubMed Zhang H, et al. 2019. Mol Cell. 76:110. PubMed Horkova V, et al. 2020. Cell Reports. 30(5):1504-1514.e7.. PubMed Duan H, et al. 2021. J Clin Invest. 131:. PubMed Schilke RM, et al. 2020. Immunohorizons. 0.624305556. PubMed XS R, et al. 2015. Diabetes. 64 90. PubMed Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed Port JR, et al. 2020. J Virol. 94:. PubMed Nadrah K, et al. 2015. PLoS One. 10: 0136061. PubMed Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed Lebel MÈ, et al. 2020. Nat Commun. 3.051388889. PubMed Gamrekelashvili J, et al. 2021. Bio Protoc. 11:e4007. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed Loo CS, et al. 2020. Immunity. 53:143. PubMed Nabet BY et al. 2017. Cell. 170(2):352-366 . PubMed Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed Kwok T, et al. 2022. Front Aging. 3:838943. PubMed X X, et al. 2016. J Immunol . 197: 1683-1691. PubMed Kurowska-Stolarska M, et al. 2016. J Allergy Clin Immunol. S0091-6749(16)31132-0. PubMed Guendel F, et al. 2020. Immunity. 53(5):1015-1032.e8. PubMed Chakraborty M, et al. 2021. Cell Reports. 34(2):108609. PubMed Urata S, et al. 2018. PLoS Pathog. 14:e1007172. PubMed Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed Gao Z, et al. 2022. J Inflamm Res. 15:3337. PubMed Jing Y, et al. 2021. Front Immunol. 12:651860. PubMed Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed Wang Y, et al. 2020. eLife. 9:e57438.. PubMed Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed Wilmore JR, et al. 2022. Front Immunol. 12:791095. PubMed Hobbs BE, et al. 2021. Pathogens. 10:. PubMed Sheppard S, et al. 2021. Cell Reports. 35(9):109210. PubMed Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed Loo Yau H, et al. 2021. Molecular Cell. 81(7):1469-1483.e8. PubMed Iwanami N, et al. 2020. iScience. 23:101260. PubMed Hildreth AD, et al. 2020. STAR Protoc. 1:100113. PubMed Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed Geary CD et al. 2018. Cell reports. 24(8):1949-1957 . PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed Mesin L, et al. 2020. Cell. 180(1):92-106.e11.. PubMed Leruste A, et al. 2020. Cancer Cell. 36(6):597-612.e8.. PubMed Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed Aurélien Trompette et al. 2018. Immunity. 48(5):992-1005 . PubMed
RRID: AB_493730 (BioLegend Cat. No. 109821) AB_493731 (BioLegend Cat. No. 109822)
Structure: Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution: All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice
Function: Phosphatase, T and B cell activation
Ligand/Receptor: Galectin-1, CD2, CD3, CD4
Biology Area: Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family: CD Molecules
Antigen References: 1. Suzuki K, et al. 2000. Immunity 13:691.
Gene ID: 19264
UniProt: View information about CD45.2 on UniProt.org
Clone: 104
Regulatory Status: RUO
Other Names: Ly-5.2, LCA
Isotype: Mouse (SJL) IgG2a, κ